Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab plus azathioprine for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis
2011-004569-33Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) comparing Belimumab + azathioprine with Placebo + azathioprine (2 arms). Primary endpoint: Time to first relapse. Started Nov 2012; status: completed.
02
Drugs
belimumab
03
Conditions
granulomatosis with polyangiitis (GPA)microscopic polyangiitis (MPA)
Beyond the preview
Go deeper on 2011-004569-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004569-33.